Ibritumomab tiuxetan

Ibritumomab tiuxetan is used to treat non-Hodgkins lymphoma. This medication contains radioactive elements; it finds cancer cells and uses radiation to destroy them. It is usually prescribed to patients who have not been able to eradicate cancer via less aggressive treatment.

Side Effects/Warnings

Patients may have a severe allergic reaction to this medication, especially after the first dose. The first dose should be given in a hospital where patients can be kept under observation for 24 hours to make sure they don’t have a negative reaction. Swelling of the face, hives or difficulty breathing are symptoms of this reaction that must be treated right away.

This medication causes patients’ blood cell count to become low. As a result, patients become extremely susceptible to infections. See your doctor immediately if you have a fever, sore throat or chills. You should also seek medical attention if you begin bruising easily or bleeding excessively.

/* Css */ /* Form */

Free Consultation

Contact Jacoby & Meyers
Dangerous Drug Lawyers

Call us Today 800-977-5614

Have you or your loved one suffered an injury?
Yes No
Was Medical Treatment required for the injury?
Yes No
By submitting this form, I agree to be contacted by an attorney from Jacoby & Meyers or one of it sponsors and I hereby acknowledge that I have read the Terms and Condition and I agree to all of its terms and conditions.

*Required Fields

Dangerous Drugs Listing